Skip to main content
Premium Trial:

Request an Annual Quote

Prodesse to Remove Three ASRs From US Market, Submit Them for FDA OK

NEW YORK (GenomeWeb News) — Prodesse said today it will stop selling three of its multiplex ASR products in the US Aug. 1 as it transitions them into in vitro diagnostics in light of a recent US Food and Drug Administration draft guidance.
 
The company said it plans to remove the underlying supermixes for its Hexaplex, Hexaplex Plus, and ProPneumo-1 products as part of an “orderly transition” from ASRs to IVD assays.
 
“Though the actual ASR regulations have not changed, the September 2006 ASR draft guidance documents clearly show that the FDA’s posture towards ASRs has changed,” Prodesse CEO Tom Shannon said in a statement.
 
”Our company prefers to clear up any ambiguity in our customers' minds by moving from ASRs to IVDs,” Shannon added.
 
The company said its ProFlu+ test for influenza A, B, and RSV has completed clinical trials and a 510(k) application will “shortly” be submitted for FDA clearance.
 
The FDA has also received a pre-IDE submission on Prodesse’s Pro hMPV+ test for human metapneumovirus. More studies are in the planning stages, Prodesse said.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.